007, the double 11 party when the President came to power, this was a chaos in film and television marketing!

    1905 movie network news On the day of "double 11", an "double 11" party, which lasted for more than four hours, was held in the Beijing Water Cube last night, in order for all the people in China to happily buy it in buy buy. According to incomplete statistics, the local tyrants’ party, which cost more than 50 million yuan, was created by our Chinese New Year director Xiaogang Feng. So, apart from fancy telling everyone what to buy, one of the highlights of this party is the placement of movie advertisements (of course, this is also the specialty of small steel cannons). Looking at the whole party, Mr. Ma Yun, our gang leader and spokesman of local tyrants, told everyone that working for BAT in the film industry is by no means a sham.

 

    From to, several upcoming Chinese New Year blockbusters, and then to popular American TV series, plus the appearance of all-star cast, this is not a party, it is simply a big chaos in the marketing implantation of film and television circles: when the propaganda dog meets single dog, it is simply a broken heart for the film.

 

Ma Yun and daniel craig came to the finale.

007 Most Surprise: Ma Yun "shows off" the color for "Bond" daniel craig.

 

    As early as the opening of the "Double Eleven" party, the hosts sold a pass and said meaningfully, "Cats’ paws extend to all parts of the world". Two-thirds of the party, Jane Zhang sang the theme song, and after the song ended, he told everyone that "007 will be released soon, don’t miss it", and the suspense escalated — — Please note that this is the first oral broadcast time of the star.

 

    At almost zero o’clock, the whole party ushered in a surprise and climax: daniel craig in "007: Ghost Party" really came, and what is even more incredible is that the "bond girl" came from our gang leader, and there was a classic picture of Ma Yun standing at Bond’s gun with a wig and heavy makeup on the big screen. "Ladies and gentlemen, you are not mistaken, he is our’ bond girl’!" With the excitement and screaming of the host, the "Wang" appeared in a suit and tie, and came to work with Mr. Bond, a British agent, to send 11 luxury cars for everyone!

 

    As the 24th Bond film series, The Ghost Party’s trip to China was very grounded. daniel craig, who has always been unsmiling and cool and arrogant in the film, showed his closeness to the people, so he boarded the "double 11" party handsomely and coolly, spent a full moon with Ma Yun’s "bond girl" and "bachelor night". Later, he will also meet with "bond girl". — Do you still feel too far away from such a cold British agent?

 

Xiaogang Feng went on stage to sell advertisements.

Feng Family: The producer’s Bad Guy Must Die and the actor’s mr. six are indispensable.

 

    Using stars to attract the audience is an essential means of the party. So how to let the stars promote their own resources by the way, then Xiaogang Feng’s best "advertising implantation" will begin.

 

    The most interesting (or controversial) passage in the whole party was the talk show "Strange Goods" with fancy advertisements brought by Zhao Wei, Ma Dong and Gao Xiaosong: three people brought their own props, changed their ways to promote their own red wine, "Strange Flowers" and "Strange Talks with Xiao Song". In fact, this slightly embarrassing talk show is a "hard and wide" that says no advertising but no words.

 

    Xiaogang Feng, the general director, also pretended that he couldn’t stand it, and ran to the stage to "bomb" the three of them, and then swaggered for his starring "mr. six" directed by Guan Hu. In addition, Xiao Gang Bao also invited the Korean rock band CNBLUE to sing the theme song "cinderella" of the Chinese-Korean co-production film "The Bad Guy Must Die" produced by him. This "softness" of the handsome sunshine fresh meat men really hit the hearts of the post-90 s, causing fans to be elated and shouting "Ouba, get stuck!"

 

The famous American singer adam lambert took the stage.


The president of "House of Cards" teased the Double Eleven.


American TV series: "House of Cards" and "Game of Thrones", American presidents want buy buy to buy them!

 

    After taking care of the post-90s generation of Ha Han, how can we neglect the young and middle-aged people who love watching American TV series? The joining of American TV series in the party is really deeply rooted in people’s hearts, and House of Cards and Game of Thrones also appeared one by one. Kevinspacey fowler, the "American President" in House of Cards, loves to get humor back at the party. Previously, he was most praised for suddenly turning around at the Golden Globe Awards, and a "house of cards" style spit came to his seat. This time, China was far away, so he recorded a video in the "White House". He even laughed and said that the firewall in the White House was tight, and he wanted to shop but couldn’t do it at all. Then he stood up and told everyone how to "cross-dress" at ordinary times. I believe that his Taobao version will be available with the search soon.

 

    In addition, when adam lambert, a famous American singer, sang on stage, she was sitting in a chair full of precious knives in Game of Thrones, and she was proud from beginning to end, which made American TV dogs not lick their screens and become materialistic.

 

TFboys

Talk about live broadcast again: exhausted film shooting techniques TFboys backstage dressing live show.

 

    The whole live broadcast not only caused many singers to fall into the hardest hit areas, but it is noteworthy that Xiaogang Feng used a lot of filming positions and photography techniques to show the party scene in many directions. For example, TFboys, these small fresh meats, are all delicious and attractive, and the cameras at the party have met the wishes of the broad masses of the people. After the end of one of their songs, the camera has been following TFboys to step down. The details of the three people’s changing scenes and discussions with the staff are truly displayed, which is a bit like the feeling of being in the mirror. After the party, many viewers felt: The original live broadcast can be played like this, thanks to the camera!

 

    In addition, as soon as Hua Chenyu opened the scene, he rocked up from just below the stage, and only Hua Chenyu used this seat for the whole party. Farewell to the fixed seat and simple push, pull, shake, move, follow, rise and fall, showing a dark and heroic temperament.

 

    When the festival in single dog was gradually replaced by the "Chop Hands" Festival, it became an out-and-out shopping carnival, and at the same time, it gradually became a national carnival in a wider range, including entertainment circles and film and television circles. Online sales are constantly setting a new record, and movies and stars are also infiltrating bit by bit unconsciously. Just before you notice any clues, in fact, the advertisements have been broadcast and the publicity has been completed. However, the people who don’t know the truth have to continue to buy in buy buy and silently sigh: "The city will play!"

 

The collapse of the working face at the construction site pulls off the water supply and gas supply pipeline.

Yesterday afternoon, an accident occurred at a rail transit construction site on Nanbin Road, Nan ‘an District. Hundreds of square meters of ground in the construction site suddenly collapsed, and underground gas and tap water pipelines were pulled off. Due to the gas leakage, a fire was also ignited.

At four o’clock in the afternoon, some citizens found that there was an abnormal sound coming from the construction site of this rail transit, and soon a raging fire broke out.

Witnesses said that after hearing the abnormal sound, they saw a large area of ground collapse in the construction site, and the gas pipes and water pipes located in the collapsed area were broken one after another.

It is understood that after the incident, this area of Nanbin Road stopped water and gas. According to the on-site construction personnel, there were signs of ground subsidence at that time, and the workers had already evacuated.

The repair personnel said that the gas pipeline has been repaired and the gas supply in the residential area has basically resumed. The water supply pipeline is being welded at the end, and the normal water supply can be fully restored at night. According to reports, no one was injured in the accident and the cause of the accident is still under investigation.

The business income of multinational pharmaceutical companies in China market surfaced, with Merck and AstraZeneca both exceeding $5.8 billion.

  【Industry trends of pharmaceutical networkBased on the huge market demand in China and the continuous optimization of the policy environment, many foreign pharmaceutical companies have actively increased the layout of the China market and achieved good results. With the global pharmaceutical companies disclosing their 2023 financial reports one after another, their business income in China market also surfaced.
 
  According to combing, in 2023, Merck’s business income in China reached 6.71 billion US dollars; AstraZeneca’s business income in China reached $5.876 billion; The business revenues of Novartis, Sanofi, Roche, Novo Nordisk and Lilly in China were US$ 3.267 billion, US$ 3.184 billion, US$ 3.171 billion, US$ 2.42 billion and US$ 1.54 billion respectively.
 
  According to the 2023 financial report released by Merck, the company’s global sales in 2023 were US$ 60.1 billion, a year-on-year increase of 1%; The net profit of returning to the mother was $365 million, a year-on-year decrease of 97.49%. Among them, Merck’s revenue in China in 2023 was USD 6.71 billion, accounting for 12.5% of the company’s global market, with a year-on-year increase of 32%.
 
  According to the industry, Merck has successfully seized the growth opportunity of China market by continuously introducing new original drug products and cooperating with local companies. In 2023, Merck’s layout and strategy in China market received positive feedback and became a multinational pharmaceutical company with good performance in China in 2023.
 
  According to AstraZeneca’s 2023 results, the company’s total revenue in 2023 was 45.811 billion US dollars (+3%), of which product revenue was 43.789 billion US dollars, up 2% year-on-year. After deducting COVID-19’s products, the total revenue was US$ 45.488 billion, up 13% year-on-year. In terms of regional distribution, the annual income of the US market was US$ 19.077 billion, a year-on-year increase of 6%. Emerging markets reached US$ 12.025 billion, a year-on-year increase of 2%. Among them, China contributed US$ 5.876 billion, accounting for 13% of AstraZeneca’s global market.
 
  It is understood that since the beginning of this year, AstraZeneca has also continuously increased its production and R&D layout in China. For example, in early March, AstraZeneca and Wuxi officially signed a cooperation agreement on a new small molecule innovative drug factory project with a total investment of 475 million US dollars, which will realize the production of specific small molecule drugs from preparation to packaging in Wuxi, and strive to build AstraZeneca into one of the global production and supply bases in China.
 
  AstraZeneca recently announced that Shanghai has become its fifth largest global strategic center. Shanghai, China will become a global strategic center integrating R&D, commerce, production and operation in addition to the four R&D-oriented strategic centers in Cambridge, Boston, gaithersburg and Gothenburg, Sweden, and become an important strategic fulcrum for AstraZeneca’s global strategy, R&D and long-term development.
 
  According to the 2023 financial report released by Novartis, the company’s annual revenue in 2023 was 45.44 billion US dollars, a year-on-year increase of 10%; Net profit was $8.572 billion, up 62% year-on-year. In 2023, Novartis achieved an operating income of $3.3 billion in China, a year-on-year increase of 17%. It is reported that in terms of production capacity, Novartis announced on December 1, 2023 that it plans to invest more than 600 million yuan to set up a radiopharmaceutical production base in Haiyan, Zhejiang, in order to accelerate the pace of introducing innovative radioligand therapy into China.
 
  According to the 2023 financial report released by Sanofi, the company’s sales in 2023 reached 43.07 billion euros (46.52 billion dollars, converted at the current exchange rate of 1 euro =1.08 dollars, the same below), a year-on-year increase of 5.3%. From the geographical distribution of income, the US market is still the main battlefield of Sanofi, contributing 18.512 billion euros (about 20.243 billion US dollars) in revenue, up 4.8% year-on-year; China’s market revenue was 2.912 billion euros (about 3.184 billion US dollars), and its growth rate also slowed down (0.4% in 2023 and 6.2% in the same period last year).
 
  It is reported that in 2023, Sanofi was approved for 12 innovative products and indications in the China market. Earlier, it announced that it planned to introduce 25 innovative products and indications in China from 2020 to 2025. With the approval of Le Weichu, the first respiratory syncytial virus prevention method for all infants at the end of 2023, Sanofi announced that it would achieve its goal two years ahead of schedule.
 
  In addition, Roche achieved a total revenue of US$ 65.627 billion in 2023, including China business income of US$ 3.171 billion, an increase of 6%. In 2023, Novo Nordisk’s revenue reached about 33.771 billion US dollars, a year-on-year increase of 31%; The company’s operating profit also increased by 37%, reaching about $14.914 billion, of which China’s business income was $2.42 billion, an increase of 11%. Lilly achieved revenue of $34.124 billion in 2023, up 20% year-on-year, net profit of $5.24 billion, down 16% year-on-year, and revenue of China District was $1.540 billion, up 11% year-on-year.
 
  Disclaimer: In any case, the information or opinions expressed in this article do not constitute investment advice to anyone.

The Big Four covers 45% of the market, and the stores are diversified and transformed into the normal state | North American accident car maintenance chain TOP10

introduction

In the first two weeks, Xiao Bian took stock of the list of quick oil change and quick repair and quick maintenance chains in the United States.Some enthusiastic readers left a message saying that they hope to have another issue dedicated to introducing the American accident car maintenance chain. Well, this is the introduction.

Executive summary:

  • The Big Four are currentlymainofThe growth means is to buy small accident car maintenance chain;

  • It is estimated that before 2021,The Big Four will cover 45% of the American accident car repair market;

  • The speed of merger and reorganization slowed down, and the giants began to consider purchasing strategic clusters;

  • technologyinnovateIs playing a role in promoting market changes;

  • outletsDiversified transformation will become the norm.

A brief introduction to the top 10 accident car maintenance chains in the United States

1. Boyd group,One of the four giants of the American accident car maintenance chain,Founded in 1990 and headquartered in California, USA,It owns Boyd Autobody & Glas,Gerber Collision & Glass andOther accident car maintenance chain.about4,170 employees,the year of 2016The annual output value is578.3 million dollars,haveMore than 400Direct sellingStore.

Its latest acquisition list is:Assured Automotive, Craftmaster Auto Body and Champ’s Holding Company, LLC.

Gerber, who was famous then, is now.A subsidiary of Boyd group,Founded in 1937, headquartered in Illinois, USA, aboutThere are 498 employees,the year of 2016The annual output value is50 million dollars.

Its latest acquisition list is: Faith Autobody Repair Centers..

2. Service King,One of the four giants of the American accident car maintenance chain,Founded in 1976, headquartered in Texas, USA, with about 4,686 employees,the year of 2016Annual output valuefor549 million dollars, with more than 300 direct stores.

Its latest acquisition list includes: First Impressions Collision, Inc., The Body Shop Collision Center and Auto World Paint and Body.

In addition, there were rumors in the first half of this year.Service KingWill soon be acquired, I wonder if it is true.

3. ABRA,One of the four giants of the American accident car maintenance chain,Founded in 1984, headquartered in Minnesota, USA, with about 613 employees,the year of 2016Annual output valuefor100 million dollars, with more than 300 stores, direct sales+joining.

Its latest acquisition list includes: Lehman’s Garage, MGM Collision South, Inc. and Keenan Auto Body..

4. Caliber Collision, one of the four giants of the American accident car maintenance chain,Founded in 1997, headquartered in.United States of AmericaTexas,about6,444 employees, 2016The annual output value is89 million dollars, with more than 500 direct stores.

CalibeR Collision’sThe latest round of financing was in 2013.Raised $60 million, and the main investor was Penfund.

thatThe latest acquisition list includesCollision care auto body centers Inc., Craigs Collision Ctr and Automotive Collision Tech.

5. MAACO,Founded in 1972,A subsidiary of Driven Brands,Headquartered in North Carolina, USA,Franchise mode. general headquartersaboutThere are 65 employees,the year of 2016Annual output valueIt is $91 million and has more than 500 franchise stores.

Its latest acquisition list is: Spray Glo Auto Refining & Body Repair and 1-Day Paint & Body Centers, Inc.

6. CARSTAR,Founded in 1989, a subsidiary of Driven Brands, headquartered in Kansas, USA,Franchise mode. general headquartersabout306 employees,the year of 2016Annual output value23.2 million US dollars, with more than 500 franchise stores in the United States and Canada.

7. Fix Auto,Founded in 1997, headquartered in Blainville, Canada, it began to implement franchise mode (joining) in the United States in 2011. The number of stores is unknown, and the annual output value is unknown.

Its latest acquisition list is:Novus Glass, Speedy Glass and Speedy Corporation.

8. Joe Hudson,Founded in 1989, it is a family business with 56 direct stores, with unknown number of employees and annual output value.

9. Cooks Collision, Founded in 1979, headquartered in California, 39Direct sellingShop,The number of employees is unknown and the annual output value is unknown.

10. Classic Collision,Founded in 1983, currently19Direct sellingStore, located in Atlanta, family business,The number of employees is unknown and the annual output value is unknown.

2. The latest development of accident car maintenance chain in the United States

Last week, Vincent Romans, CEO of Roman Consulting Company, expressed his latest views on the accident car maintenance industry in the United States at the seminar on the development of accident car maintenance chain in Chicago Auto Show.

1. The market in the next five yearspredict

Vincent predicts that before 2021, the market share of the above-mentioned four giants, such as Boyd Group, will continue to grow, covering nearly 45% of the American accident car repair market, equivalent to a share of $16.7 billion (he estimates that the share of the entire accident car market segment is about $37.6 billion).

There are also 55% shares belonging to those small chain stores and single stores.

Vincent said: "We are now at another stage of the industry.Industry consolidation continues, but the speed has obviously slowed down. The Big Four are in no hurry to buy small chains at this stage.Instead, we are considering purchasing strategic clusters. "

"The market is currently in a temporary equilibrium state," Vincent said. "However, in the next two or three years, we will have another large-scale market contraction."

"At present, all kinds oftechnologyInnovation is playing a driving role, "Vincent said.

Diversified transformation in the industry will become the norm, which will lead to various simple and complex partnerships, alliances and market segments will be integrated.

2. Market conditions affecting the industry

At the meeting, Vincent cited various market conditions that affected the industry: stores increased DRP;; Advanced driver assistance system and automatic driving technology; Remote information processing; Supply chain integration;Alternative assessment model of margin pressure;predictive parsing;Photo evaluation;Main engine factory; The speed of technical iteration;Population, urbanization and changing lifestyles, etc.

3. Private equity players also join in the fun.

Private equity funds have also entered the PBE supply chain.VincentIt is mentioned that PNC RiverArch Capital acquired Painter’s Supply, 21 of which are located in Michigan, Ohio and Indiana. Driven Brands cooperated with many private equity groups to establish a wider MSO (multi-store operation, which means chain operation) group franchise network in its Maaco and CARSTAR.

If they come together, it may not have that great influence, but together, they can be very powerful.VincentSay.

The above is a brief introduction to the American accident car maintenance market at this stage.

The 3000-point A-share defense war has been restarted. What’s the difference this time?

  On April 25th, the Shanghai Composite Index closed down by 5.13%, and fell below the 3,000-point mark again after 22 months to 2,928.51 points, bringing a general decline covering more than 96% of the stocks.

  Why did A shares plummet? Many institutions believe that it is the result of the failure to effectively hedge external risks and internal benefits under multi-factor resonance. A shares will be repaired, but it will take some time.

  Overseas markets are surging — — James Bullard, a well-known hawkish official of the Federal Reserve, refused to rule out the possibility of raising interest rates by 75 basis points (BP) in early May. According to CME’s FedWatch tool, the probability that traders will raise interest rates by 75BP at least once in the next two meetings is over 95%. In the first quarter, US stock earnings reached a climax this week. Five-sevenths of the companies with the largest market capitalization in the United States will release earnings reports, mainly technology giants, which will naturally become the focus. The agency expects that the overall profit growth rate will be the lowest in the past five quarters. US stocks plunged last Friday, with the Dow falling by 1,000 points.

  At the same time, on the 25th, the offshore RMB broke through the 6.6 mark against the US dollar, with the depreciation rate exceeding 2,400 points since the beginning of the year. As of 16:30, USD/onshore RMB reported 6.5544, down 669 points from the previous closing price, the lowest since April 2 last year; As of 18:49, USD/offshore RMB reported 6.6041. Then, the central bank announced that it would reduce the foreign exchange reserve ratio, and the offshore RMB rebounded by 300 points in the short term to near 6.5738.

  The Shanghai Composite Index fell below 3,000, and the hot stocks plunged.

  Affected by weakening market sentiment, the Shanghai Composite Index fell below 3,000 points on the 25th. After the resumption of the market performance during several RMB devaluations since 2015, the overall market was dominated by decline, with relatively dominant value and finance in style, and its growth was greatly affected.

  Since April, the major indexes have continued to fall by shocks. Last week, the Shanghai Composite Index and the Shanghai and Shenzhen 300 Index fell by 3.87% and 4.19% respectively, while the Growth Enterprise Market fell by 6.66%. At the industry level, textile clothing benefited from the depreciation of RMB exchange rate, rising by 4.93%, while the decline of electricity and public utilities, food, household appliances and transportation was relatively small; Real estate, steel, nonferrous metals, coal, medicine and building materials were among the top losers.

  On the 25th, the hot stocks fell sharply, including the Internet, basic metals, education, chemical raw materials, leisure products, aerospace and military industries, which fell by more than 8%, while the popular concept sectors including photoresist, sodium ion batteries, industrial metals, semiconductor equipment, aluminum industry and online education fell by more than 9%. Even the COVID-19 antigen testing, large-scale infrastructure, generic drugs and other sectors, which once became the concept sector of A-shares rising against the trend, fell by more than 3.5% on that day. Short positions favored by foreign investors, such as China Merchants Bank, New China Life Insurance, Wuliangye, Contemporary Amperex Technology Co., Limited and Longji, all fell more than 5%.

  At present, it is in the intensive release period of a quarterly report, and some manufacturing growth leaders have slowed down their performance growth or failed to meet expectations, which may lead to a decline in stock prices and suppress the overall performance of A shares. For example, Hengrui Pharma, the leading pharmaceutical stock, plunged at the opening, and fell sharply in intraday trading, closing at 29.7 yuan/share, hitting a three-year low. Another example is Longji shares, which fell by 8.69% to 56.61 yuan/share on the 25th after many days’ decline, and the market value of one day evaporated by 29.176 billion yuan.

  According to the reporter, on the 25th, the total market value of 4,799 listed companies in the city evaporated to 4.58 trillion yuan. Since the beginning of this year, the average decline of the above 255 listed companies is as high as 19%.

  A number of institutions told reporters that the sharp drop in A shares was the result of the failure to effectively hedge external risks and internal benefits. "It is precisely because the weak rebound expectation is broken that the market is moving in an extreme direction." Yan Kaiwen, chief strategist of Huaxin Securities, said.

  Li Meicen, chief strategist of Caitong Securities, also put forward the theory of "dislocation". "At present, the external economy is at a high level, China’s economy is at a low level, and the economic fundamentals are at the biggest dislocation stage. The external is receiving, we are releasing, the exchange rate expectation pressure is high, the stock market stock game, and the liquidity is more pessimistic. " The two-way dislocation inside and outside, coupled with the repeated epidemic, the constant thunder in the first quarter, the recovery of supply chain and the recovery of consumption have not improved, so the Shanghai Composite Index is close to the previous low again, and investors are more pessimistic.

  How does the exchange rate affect A shares?

  Since 2010, there have been eight obvious cycles of RMB depreciation, in which A shares rose four times and fell four times. Specifically, after the "811 Exchange Reform" in 2015, the RMB exchange rate experienced four obvious devaluations. The first two times were the narrowing of the spread between China and the United States caused by the tightening of the Federal Reserve, and the macroeconomic kinetic energy was "strong in the United States and weak in the middle". Corresponding to the performance of the stock market, both the broader market and the industry closed down.

  The probability that RMB depreciation is positively related to the decline of A shares is 50%. There is no direct causal relationship between the stock market and the exchange rate, but the exchange rate is usually a reflection of the basic market. At the same time, with the increase of the participation of overseas investors in A shares, the impact of foreign capital flows on A shares is increasing. Therefore, Yan Kaiwen believes that the rapid depreciation of the RMB exchange rate since 2018 has a dominant impact on A shares, and at the same time, such impact will be amplified in the weak stage of A shares.

  "The market expects more steady growth policies and measures to stabilize the economy and market expectations, thus boosting investor sentiment. The current market uncertainty is more prominent. Seeing more and doing less is still a more suitable investment strategy for ordinary investors. The opportunities after the direction is determined are easier to grasp. " Yuan Huaming, general manager of Huahui Chuangfu Investment, said.

  Li Meicen said that this week is a crucial week, and the uncertainty that investors pay attention to is becoming clear. On the one hand, with the improvement of the domestic epidemic situation and the recovery of the supply chain, the domestic economy will run upwards, and corporate profits are expected to gradually stabilize and rebound. On the other hand, in the case of less incremental funds, the market showed a situation of stock game in the first half of the year. If the Federal Reserve did not make a more "eagle" statement later, with the comparative advantage of China’s economy highlighted, overseas funds may flow back to emerging markets, especially the China market with significant allocation value in the medium and long term.

  As for the follow-up trend of the exchange rate, the most critical export data has not changed much, and there is no sign that the capital outflow will continue to accelerate significantly. The weakening of the emotional side is the main reason. "At present, offshore hedge funds have begun to make more dollars against the RMB. Although there are many uncertainties and even some institutions are at a loss, it seems more mainstream to make more dollars in the short term." A foreign bank strategist told CBN.

  Another foreign trader told reporters: "Let the bullets fly for a while." In fact, from October last year to the beginning of last week, the RMB kept in the range of 6.3, and the fluctuation was unusually low, and there was no trace of offshore short positions. At that time, China’s exports continued to be strong, and domestic US dollar deposits reached 1.1 trillion US dollars, which also made enterprises unwilling to buy US dollars. Moreover, before that, the RMB yield was still higher than the US dollar, and shorting the RMB required a spread. However, at present, the situation has reversed, and even if the prospects are highly uncertain, offshore institutions have begun to test the water and short.

  The spread between China and the United States has been upside down for nearly two weeks. As of the close of 25th, the yield of China ten-year treasury bonds 220003(22 interest-bearing treasury bonds 03) was 2.8325%. The yield of US 10-year Treasury bonds was reported at 2.828% on Monday, down from the high of 3% hit last week, but it is still expected to rise in the future.

  However, around 19: 20 on the 25th, the central bank announced that it would reduce the foreign exchange deposit reserve ratio of financial institutions by 1 percentage point, that is, from the current 9% to 8%. This means that the market dollar liquidity will increase, releasing the signal of the central bank to stabilize the RMB.

  "This is more symbolic, with a range of only 1%, but it also shows that the central bank is happy to see the two-way fluctuation of the RMB, but it does not want to see the exchange rate depreciate sharply too quickly." The above traders told reporters that the maximum release of US dollar liquidity was US$ 10 billion, which was still relatively small compared with the daily average US$/RMB trading volume in the onshore market of US$ 39 billion.

  In fact, before this RRR cut, the central bank "increased the RRR" twice last year, each time by 2%, and the foreign exchange reserve ratio rose from 5% before June last year to 9%. At that time, the central bank intended to slow down the appreciation of the RMB. In 2021, due to strong exports and accelerated inflow of foreign capital, the RMB once rose to around 6.3.

  Be wary of the Fed raising interest rates by 75BP in May.

  In the next two weeks, the financial reports of overseas central banks and US stocks will be the focus of the market, which will also have an impact on the RMB and China stock market.

  US stocks closed down sharply last Friday. The Dow hit its biggest one-day drop so far this year, closing down 981.36 points, or 2.82%.

  The increasingly hawkish stance of the Fed is the main reason. Federal Reserve Chairman Powell said last week that "it is possible to raise interest rates by 50BP at the meeting in May", while Brad refused to rule out the possibility of raising interest rates by 75BP next month.

  "It is becoming increasingly clear that the Fed is accepting the view that it needs to raise interest rates extremely aggressively to control inflation. The Fed has never raised interest rates by 75BP at one time since 1994, but the hint of raising interest rates by 75BP seems not so bizarre to almost all of us now. In fact, according to CME’s FedWatch tool, traders now count the chances of raising interest rates by 75 basis points at least once in the next two meetings of the Fed to exceed 95%. " Matt Weller, head of global research at Jiasheng Group, told reporters.

  "In view of this, the volatility of all markets is likely to remain high for the rest of this year." He said. The core PCE report will be released this Friday, which is the most favored inflation indicator of the Fed, and it has been rising for five months. Judging from the early estimates, the core PCE may remain unchanged at 5.4% this time. If the reading is unexpectedly higher than expected, it may open the door to raising interest rates by 75BP as soon as next Thursday, which may be highly profitable for the US dollar and bad for the US stock market. As of 17: 50 Beijing time on the 25th, the US dollar index stood at 101.573.

Test drive Dongfeng Yipai e π 008:5 meters long + 3 meters wheelbase, 200,000 intelligent 6-seat SUV

Recently, it unveiled its second model, Dongfeng Yipai eπ 008, which is positioned as a "family intelligent large SUV". It has a length of 5002mm, a wheelbase of 3025mm, and a 6-seat home layout of "2 + 2 + 2". The excellent body size makes Dongfeng Yipai eπ 008 have very strong space attributes, making it a veritable "536" model. In this regard, we have also had a test drive experience of the vehicle and share with you some of the experience after the test drive.

In the actual test drive, the eπ 008 has three modes: pure electric priority, fuel priority, and mixed gasoline and electricity. The power response is still very positive, and it is more suitable for household use. It is recommended to drive pure electric priority in daily cities. While saving energy and being cost-effective, you can also enjoy the light driving experience brought by the tram.

When passing through the fine and bumpy road section, the filter of Dongfeng Yipai Eπ 008 is relatively in place, and it is generally comfortable. In steering, although driving such a big guy, the steering is still very flexible and not clumsy.

The NVH performance of the new car is also good. The eπ 008 uses 265/45 R21 size Continental silent tires. When driving on the gravel road at a speed of 90km/h, the noise in the car is about 75.8dB. When driving on high-speed sections, the wind noise control is good, and the wind sound is hardly audible. However, the tire noise of the vehicle is slightly obvious, which may be caused by the large tire width.

After saying dynamic, look at static

From the appearance, the EPi 008 adopts a closed front face design, which is also one of the popular features of the moment. The entire front part looks very sturdy, giving a very heavy feeling. The through light strip divides the front face into two, and there is a relatively complex built-in light source inside, which can support a variety of lights when lit, especially at night to create a very cool atmosphere.


On the side of the body, it is worth mentioning that there is also a small window between the C-pillar and the D-pillar, which can make the third-row passengers not feel depressed. In addition, the D-pillar is also equipped with a digital rhythm charging indicator light, which will produce different light changes when the vehicle is charging. In terms of body size, the length, width and height of the Dongfeng Yipai e π 008 are 5002mm × 1972mm × 1732mm, the wheelbase is 3025mm, and the positioning of the medium and large SUV is 0.268Cd.

At the rear of the car, the eπ 008 also uses a through-type taillight, and the internal lattice light source shape echoes the front of the car, which is highly recognizable after lighting.

Entering the car, the interior of the eπ 008 continues the interior design style, which is as windy as the appearance. Although the shape is simple, the texture is online. The six-seat layout of 2 + 2 + 2 will be more suitable for large families and can take care of everyone’s comfort.

Intelligent configuration,E π 008The intelligent cockpit is composed of an 8.8-inch instrument and a 15.6-inch central control screen. The car is the mainstream chip, and the impression I get from using it is that the screen is large, the car responds quickly, and the mainstream functions can be found quickly. The voice system responds quickly, and it can be 100% voice-controlled on the car-machine interface. The overall experience does not differ much from other models.


In terms of space, adjust the second row of seats to the final state. After riding with a height of 170cm, there is still room for more than 3 punches in the legs. After adjusting the second row to the remaining 2 punches, the third row of legroom also has 3 fingers of wealth. When 6 people travel at the same time, the third row is more suitable for passengers with a height of less than 175cm.Among them, you can also choose seats, leg supports, small table boards, headrests, and sunshades on the right side, which are all equipped with rich functions.


Write to the end

As a medium and large SUV, the Eπ 008 shows excellent competitiveness in terms of appearance, interior, comfort, power and intelligent configuration. The price of the 216,600 is also relatively close to the people. Recently, there are preferential policies, and the price of the limited-time car starts from 18,86 yuan. Interested friends can go to the store for a test drive and learn about your local preferential situation by the way.

Talking about food and nutrition from a historical perspective

  Food and nutrition, as one of the brilliant cultural achievements of the Chinese nation, has taken root and sprouted in this land since ancient times and has been passed down to this day. The history of feeding can be divided into two stages: the first stage is the enlightenment and growth stage before the Tang Dynasty; The second stage is the stage of development, maturity and prosperity after Sun Simiao first put forward the theory of dietotherapy in Tang Dynasty. However, after the introduction of western medicine and nutrition into China, the concepts of food support and dietotherapy seem to become more and more vague, and their application is also confusing, lacking effective guidance. In order to trace the source and use it in order, today we mainly talk about the problem of food support before the Tang Dynasty from a historical perspective. Based on this, what we refer to as food and medicine refer to substances that have traditional usage habits and history in China, so medicine naturally refers to Chinese medicine or Chinese herbal medicines.

  First, what is food support

  According to the Book of Rites, as early as the Zhou Dynasty, there were full-time food doctors in the palace, whose main duty was to provide reasonable diet and nutrition for the Zhou royal family.

  The word "feeding and nourishing" first appeared in the "On the Five Permanent Political Powers" in the Yellow Emperor’s Classic of Internal Medicine (hereinafter referred to as the "Classic of Internal Medicine"), and it said: "The disease is new for a long time, and it is toxic and non-toxic, so it is appropriate to make it regular. Great poison cures diseases, and ten goes to the sixth; Often poison cures diseases, and ten goes to the seventh; A small poison cures a disease, and ten goes to eight; Non-toxic treatment, nine out of ten. Grain, meat, fruits and vegetables are exhausted, and they are not used to it, which hurts them. "

  Traditional Chinese medicine believes that a healthy human body should be in a state of yin and yang balance, and illness is the reason for the imbalance of yin and yang. Medication mainly relies on the bias of drugs (some of which are toxic) to intervene in the human body in order to achieve a re-balance between yin and yang. If some drugs are cold, they can treat heat syndrome; Some drugs are too hot to treat cold syndrome. This is what Chinese medicine often says: "those who are cold are hot, and those who are hot are cold." Since drugs are obviously biased, even if they are not toxic, they are not suitable for long-term use without the guidance of doctors. For example, Cordyceps sinensis is a good thing and has no toxicity, but not everyone can eat it. Even the same person is suitable for eating today, but it may not be suitable for eating after a while. Nowadays, many people always think that Chinese medicine is very safe, and it is very wrong to eat it at random without the guidance of a doctor.

  The quotation in the above-mentioned Neijing holds that medication should not be used too much, and it should stop at the stage of "healing" when the disease is cured, and use "food support" for recuperation and rehabilitation. This is to carry out rehabilitation work by choosing food with relatively more peaceful taste instead of medicine. Why do you want to do this? Neijing holds that "it hurts the righteousness". That is, I am afraid that it will hurt the healthy qi of the human body. According to modern theory, it is afraid that it will hurt the immunity and resistance of the human body. This is the source of food and nutrition.

  Therefore, we must make it clear that the so-called food cultivation is a method to prepare corresponding food for human consumption through selecting appropriate ingredients, reasonable collocation and appropriate cooking and production methods, so as to recuperate the healthy qi of human body.

  Second, the connotation of food support

  As mentioned in the above quotation, when drugs are used to treat diseases, whether toxic or non-toxic, they should stop when the disease has gone to its sixth, seventh, eighth and ninth, and use more peaceful food instead of drugs to complete the aftercare work. I am afraid that if drugs are used blindly, even if they are non-toxic, their bias will damage the healthy qi of the human body. Therefore, the first aspect of the connotation of food and nutrition is the embodiment of the traditional Chinese medicine’s thought of "stopping the disease in the middle" and "eliminating evil without hurting righteousness" We modern people are always anxious to see the disease well, but often fall into the situation of overtreatment without knowing it. It is sad that children are eager to use antibiotics to reduce their fever as soon as they have a fever, so as to reduce their parents’ own worries and troubles.

  There is a saying in the article "On the Time of Dirty Qi Method" in Neijing Su Wen: "Poison attacks evil, grains feed, five fruits help, five animals benefit, five dishes are filled, and the smells are combined to supplement lean qi."

  Five grains, five fruits, five livestock and five vegetables are all foods. When they are used reasonably and balanced in nutrition, they can achieve the effect of replenishing essence. Supplementing essence and qi belongs to the category of "strengthening the body" mentioned by traditional Chinese medicine. "Eliminating pathogenic factors" and "strengthening body resistance" are the main methods of treating diseases in traditional Chinese medicine. The so-called eliminating pathogenic factors means using the partiality of drugs to eliminate pathogenic factors in the body, just like marching to fight, which means expelling the enemy from the country; The so-called righting means mainly using some drugs with tonic effect to support and cultivate healthy qi in the body, which means strengthening the strength of one’s own army. From the interpretation of Neijing, the righting can be done not only by drugs, but also by reasonable diet. Therefore, the second connotation of food support is the embodiment of the thought of "strengthening the body" in traditional Chinese medicine.

  Third, the content of food support

  Through the interpretation of Neijing and related classics, food and nutrition is still a guiding principle of traditional Chinese medicine, that is, the three-factor diet recuperation methods and dietary taboos due to people, time and place. The so-called "because of people" is based on individual’s different physique or illness; The so-called timing is based on different seasons or times; The so-called place is based on different regions or environments.

  The content of food and nutrition mainly includes three parts: food suitability, food taboo and food and nutrition prescription.

  The so-called food suitability refers to deciding what to eat, what ingredients to choose, what processing methods to use, etc. according to the above-mentioned three-cause principle, in order to maintain or recuperate the body to a healthy state of yin and yang. This part of the content has long been systematically expounded in Neijing, such as different foods suitable for eating according to seasons and different dietary guidance according to diseases.

  On the issue of ingredients, we must point out that many people like to add some Chinese herbal medicines to their food. For safety reasons, please be sure to look for them in the list of 87 "dual-use" Chinese herbal medicines published by the National Health and Family Planning Commission.

  About food taboos, it is also a dietary taboo based on personal health according to the guiding principles of the above three reasons. Generally speaking, food taboos generally refer to all dietary taboos, including those in healthy state, food dosage, food quality (i.e. whether it goes bad or not), food collocation and diseases. Dietary taboos during illness, commonly known as taboos, are mostly recorded in prescriptions of past dynasties.

  As early as the Eastern Han Dynasty, there were a large number of books on food classics in China (unfortunately, most of them were lost), and some food-nourishing prescriptions gradually appeared. Most of them were presented in the form of medicinal diet, such as Zhang Zhongjing’s "Pig Skin Soup", which was made of fresh pigskin, white honey and white powder, but the appearance of a large number of food-nourishing prescriptions had to wait until the Tang and Song Dynasties.

  Fourth, the application of food and nutrition

  Before Sun Simiao put forward the theory of "dietotherapy" in Tang Dynasty, the content of diet recuperation in China was mainly manifested in food support. So, what were the main applications of food support before the Tang Dynasty?

  First of all, of course, in the daily diet guidance, a reasonable diet is the application of food support.

  Secondly, it is mainly used in the rehabilitation stage after treatment. As the saying in Neijing says, "Eat and nourish everything", after the sixth, seventh, eighth and ninth diseases are removed, the recovery of the body is promoted by eating and nourishing. According to modern theory, on the one hand, it relies on its own immunity to fight against external evils, on the other hand, reasonable food and nutrition itself has a certain function of "replenishing essence and qi" to strengthen its own immunity, and a combination of the two can promote the recovery of the body. This application of food nutrition can effectively avoid the harm to human body in the process of drug use and prevent the occurrence of over-medical treatment, which is especially worth learning from. Of course, the choice of food and support depends on the specific situation.

  Thirdly, feeding and nourishing is an important way to cure the disease before it happens. Since reasonable food and nutrition can play an effective role in "replenishing essence and qi", the body will naturally be less prone to illness.

  Before the Tang Dynasty, food support was still in the stage of enlightenment and growth. The author believes that food support is not so much technology as thought and culture. In the Tang Dynasty, Sun Simiao, a famous doctor, effectively inherited and carried forward the thought and culture of food support, and innovatively put forward the theory of "food treatment". Subsequently, a large number of dietotherapy monographs and prescriptions appeared, marking the gradual transition of food support culture from the enlightenment and growth stage before the Tang Dynasty to the development, maturity and prosperity stage.

Smeagol domestic pharmaceutical companies race: Stone medicine starts clinical, East China medicine enters phase III …

On September 20th, East China Medicine announced that its long-acting glucagon-like peptide -1(GLP-1) receptor agonist Smegrutide injection phase III clinical trial had completed the first patient enrollment and administration. This is a multi-center, randomized, open and parallel controlled phase III clinical study. The main purpose is to demonstrate the equivalence of blood glucose control between the experimental drug Smegliclade injection and the control drug Smegliclade injection (Novotel) after 32 weeks of treatment in type 2 patients with poor blood glucose control after metformin treatment. According to the Insight database, the trial registration was announced on August 2 this year.

Test registration and historical time axis

56591695337258551

Coincidentally, on September 18th, Unacon’s Smegliptide Injection just started its clinical trial (registration number: CTR20232854).

Registration of clinical trials of stone drugs

60251695337258698

As a super blockbuster with annual sales of more than 10 billion dollars, smeagoutide is also competing among domestic enterprises. With the continuous advancement of clinical progress, the competition pattern is becoming more and more intense. The data show that there are as many as 12 smeagoutide similar drug projects involving domestic enterprises, and 6 of them are in phase III clinical stage.

Phase III clinical phase Smegliptide biological analogues developed by domestic enterprises.

24871695337258797
The patent of smeagoutide in China will expire in 2026. At that time, the listing of similar drugs of smeagoutide will face huge market opportunities. In addition to the diabetes market, domestic drugs are also expected to compete with the "slimming medicine" in the 100 billion blue ocean track.

01 GLP-1: Development Potential of Multiple Indications

Smegliptide has 94% sequence homology with human GLP-1, which is one of the important targets for treating diabetes. As the most eye-catching GLP-1 receptor agonist in the world at present, Novo Nordisk’s smeagoutide has achieved a total sales of over 10 billion US dollars in 2022 with its good hypoglycemic and weight-loss effects, and the total sales of smeagoutide in the first half of this year has also reached 9.23 billion US dollars. According to Jost Sullivan’s prediction, the domestic market size of GLP-1 receptor agonists for hypoglycemic is expected to reach 50.1 billion yuan in 2030.
2011695337258947

Judging from the approved indications, smeagoutide can reduce blood sugar by stimulating insulin secretion and reducing glucagon secretion, and at the same time significantly reduce the risk of major cardiovascular events (MACE) in patients with type 2 diabetes. It has been clinically approved for blood sugar control and weight loss in patients with type 2 diabetes. In addition, smegliptide is also a heavy player in the field of weight loss. The indications for obesity or overweight of novonorgestrel injection were approved by FDA in June 2021 and EMA in January 2022. Up to now, although the indications have been declared, they have not been approved in China.

Progress in the Approval of Smegliptide in Major Regions of the World

21941695337259057

Smegliptide has great market potential in the field of weight loss, and the sales growth rate has always doubled. According to the latest semi-annual report, the sales of the drug’s weight loss indication (Wegovy) was 12.081 billion Danish kroner (about 1.781 billion US dollars), up 367% year-on-year. Moreover, due to the shortage of production capacity, Novo Nordisk also stopped advertising some of the weight-loss products of Smeagol in the United States in May this year. From another perspective, this shows that the current achievements have not reached the real strength of Smeagol’s "full firepower".
55541695337259125

Not only that, but also in other diseases, Smegliptide has many possibilities to explore and treat. For example, in nonalcoholic steatohepatitis (NASH), it has been found that GLP-1 can reduce hepatic steatosis, hepatocyte injury and glucose output after combining with hepatic cell receptors, and reduce the inflammatory reaction and fibrosis of hepatocytes in NASH, which has the potential to treat NASH and is expected to fill the clinical vacancy of drugs for NASH diseases. In the field of Alzheimer’s disease (AD), in recent years, it has been found that GLP-1 may enhance aerobic glycolysis and reduce oxidative phosphorylation by activating PI3K/Akt pathway, and can alleviate the decline of astrocyte glycolysis induced by Aβ, which plays a role in neuroprotection and energy regulation therapy. A corresponding phase III clinical trial is being explored (registration number: NCT05891496). The step-HFpEF trial of smegliptide in treating patients with heart failure with preserved ejection fraction (hfpef) has entered the third phase. The results show that smegliptide can significantly improve the symptoms related to heart failure and exercise ability compared with placebo. In addition, some studies have found that smegliptide has cardiovascular protection, which reduces the risk of major adverse cardiovascular events (MACE). Under the background of "involution" of hypoglycemic and weight-reducing indications, other indications of smeagoutide will be explored, and in the future, the market space of smeagoutide may usher in another outbreak.

02 East China, Cinda, Hengrui … Domestic enterprises are sprinting.

From biologically similar drugs to innovative drugs, from single target to three targets, from injection to oral administration … domestic enterprises are also blocking the potential track in all directions.

1. East China Medicine: Wide layout and fast progress.

Among domestic enterprises, the layout of East China Medicine in GLP-1 field is excellent in comprehensiveness and leadership. In the field of weight loss, GLP-1 product lines covering oral dosage forms, injections and other dosage forms, including long-acting and multi-target global innovative drugs and biologically similar drugs, have been established, including the marketed liraglutide injection. The products under research include a variety of products, such as the biosimilar drug Smegliptide Injection, the global innovative oral small molecule GLP-1 receptor agonist HDM1002, the double-target agonists HDM1005 and SCO-094, and the long-acting triple-target agonist DR10624, so as to realize the all-round layout of GLP-1 with single target, double target, triple target and oral small molecules. Based on the advantages of the existing pipeline, Huadong Pharmaceutical indicated that it will continue to explore innovative projects related to GLP-1, expand the related indications such as lipid lowering and NASH, and continue to develop innovative drugs with higher bioavailability and more clinical advantages. Liraglutide, which is the first to be listed, is a medical insurance product. According to the documents exchanged by investors, the online work in more than 20 provinces in China has been completed, and it is expected that the online work in all provinces will be completed in September. The off-campus market is also the main sales channel, and offline pharmacies are expected to achieve the coverage of more than 30,000 chain retail pharmacies in the third quarter of this year. In the research product pipeline,The clinical trial of GLP-1R/GCGR/FGF21R long-acting triple-target agonist DR10624 for weight management of overweight or obese people was approved by CDE in July. In China, East China Medicine also submitted DR10624 for IND of severe hypertriglyceridemia in August this year. Abroad, in July, 2023, DR10624 completed the first subject administration in the phase I multiple incremental dose administration (MAD) clinical trial for the treatment of obesity in New Zealand. GLP-1R/GIPR double-target long-acting polypeptide agonist HDM1005 has entered the research stage of IND. At present, the project is progressing smoothly, and it is expected to submit an IND application in early 2024. HDM1002, a small molecule GLP-1 receptor agonist, has been reported in both China and the United States. In May 2023, its indication for type 2 diabetes was approved for clinical use in China, and the first trial was completed in June. The indication for overweight or obesity of HDM1002 tablets was also approved in September in China.

2. Cinda Bio’s next performance take-off point: Masidopeptide.

As early as August 2019, Cinda reached a cooperation with Lilly, and introduced GLP-1R/GCGR dual agonist Masculitide (IBI362).

Masidopeptide equity flow chart

94321695337259193

At present, Cinda has laid out the indications for type 2 diabetes and obesity of Masculitide in China, and both of them have been promoted to phase III clinical practice. Among similar products in China, the progress is the fastest. The results of phase II clinical study showed that among the overweight or obese subjects in China, the weight of the patients decreased by 11.57% after 24 weeks of continuous administration of 6.0mg of Mastopeptide. And compared with placebo, it can bring 12.6% weight loss. In addition, among the obese patients who need surgical treatment, after 24 weeks, the average weight loss of the group using 9mg of marsden reached 15.4% and the weight loss was 14.7kg.

Results of Phase II Clinical Trial of Masculitide

85561695337259271

The two phase III clinical codes of type 2 diabetes are DREAMS-1 and DREAMS-2 respectively, and the latter is a head-to-head clinical trial of dulaglutide; The obesity phase III clinical trial code is GLORY-1. According to the Insight database, at present, 83% of patients in DREAMS-1 have been enrolled, while the progress of GLORY-1 has been 100%.

Phase III clinical trial initiated by IBI362

17331695337259380

Cinda said that it is expected to submit the listing application of Mastopeptide from late 2023 to early 2024. In addition to type 2 diabetes and obesity, Masculitide has also been approved for clinical use in NASH, and the corresponding research on NASH will be started soon. The listing of Mastopeptide in China will also provide Cinda with the second performance take-off point after PD-1 cindilizumab, and support Cinda to achieve the goal of 20 billion revenue in the next 4-5 years.

3, Hengrui Pharma: dual agonists, oral small molecules, compound preparations …

At the GLP-1 circuit, Hengrui’s layout can also be described as comprehensive. According to the layout of GLP-1/GLP-1R target enterprises, Hengrui is also among the TOP5.

Number of GLP-1R domestic enterprises’ target layout projects TOP5

50851695337259449

Screening [target] is GLP-1/GLP-1R, excluding inactive and inactive projects for more than 3 years; Only new, improved and similar drugs are counted.

With regard to the hot GLP-1 dual-target hypoglycemic agent, Hengrui is researching GLP-1R/GIPR dual agonist HRS 9531, which has just been approved for obesity clinic in May, and has started phase II clinical research and development. In addition, Hengrui also has a GCGR antibody /GLP-1 fusion protein SHR-1816, which has also progressed to clinical stage I. In the field of small molecule oral medicine, Hengrui has HRS-7535, which has started Phase II clinical practice. In the field of compound drugs, Hengrui’s HR17031 is a GLP-1/ insulin compound drug.

Hengrui GLP-1 new drug

46221695337259508

END

Source | Insight database

Seeing the People’s Livelihood Concern in the Spring Festival Footprint of the General Secretary from his trip to Tianjin

  Spring Festival is the warmest festival in Chinese’s heart.

  On February 1st, on the eve of the Spring Festival in the Year of the Loong, General Secretary of the Supreme Leader came to Tianjin for investigation and investigation, and visited the grassroots cadres and masses.

                                                                                                   

  In recent years, in the poverty-stricken areas with deep mountains and long roads, in the border areas of the frozen motherland and in the snow-covered towns and villages, on the eve of the Spring Festival, the General Secretary of the Supreme Leader will visit the people of all ethnic groups, ask about the family, ask about the temperature, listen to the voice of the people and send blessings.

  "On the occasion of the New Year, I am most concerned about the people in difficulty. How do they eat and live? Can they have a good New Year and a good Spring Festival?"

  "As long as there is a family and even a person who has not solved the basic living problems, we can’t take it easy; As long as the people’s longing for a happy life has not yet become a reality, we must work tirelessly to unite and lead the people to struggle together. "

  … …

  Looking back, the deepest concern makes people feel warm.

  This time, the General Secretary of the Supreme Leader came to Tianjin, and the first stop was Liubu Village, Xinkou Town, Xiqing District. He learned about the recovery of local agricultural production after the flood disaster last year and visited the affected people.

                                                                                                   

  During the Spring Festival, the General Secretary of the Supreme Leader is always worried about the affected people, worrying about whether they can eat and wear warm clothes and whether their production and life have settled down.

  In February 2013, the Supreme Leader made his first inspection on the eve of the Spring Festival after serving as the general secretary, and walked along the steep mountain road into Dongxiang Autonomous County of Gansu Province, which had suffered landslide disaster. At the reconstruction site, the General Secretary requested to adhere to overall arrangement, safe construction and ensure progress and quality.

  In February 2018, General Secretary of the Supreme Leader, who was inspecting in Sichuan, made a special trip to the epicenter of the Wenchuan earthquake — — Yingxiu town, Wenchuan county, take a look at the recovery and reconstruction of the disaster area and how the people are living.

  In January, 2022, General Secretary of the Supreme Leader braved the snowstorm and cold to come to Fengnanyuan Village, Shizhuang Township, huozhou city, Shanxi Province, to inspect the reconstruction, ask about replanting and pay attention to winter.

  "I have always missed the people in the disaster area." In November last year, when inspecting the post-disaster recovery and reconstruction work in Shuiyuzui Village, Miaofengshan Town, Mentougou District, Beijing, General Secretary of the Supreme Leader said to everyone, "communist party is a party that serves the people and always puts the people in the highest position in its heart, whether it is disaster relief or post-disaster recovery and reconstruction, it will go all out."

  Go all out and do everything for the people. In the footprint of the Spring Festival, it is the constant concern of "keeping the safety of ordinary people in mind at all times".

  Leaving the warm homes and vegetable fields of the villagers in Liubu Village, General Secretary of the Supreme Leader came to Tianjin Ancient Culture Street to inspect the supply situation of the festival market.

  Bread is the staff of life. The "vegetable basket" is connected with the villagers’ harvest at one end and the dining tables of thousands of households at the other. When he was a city leader in Fuzhou, the top leader comrades took grasping the "vegetable basket" as the top priority and looked at the price of vegetables every day.

  The Spring Festival is approaching, and the "vegetable basket", "rice bag" and "fruit plate" on the shelves are related to the annual flavor concentration and the happy life of thousands of people in Qian Qian.

                                                                                                   

  The supply of holiday market is a matter that the Supreme Leader General Secretary often pays attention to on the eve of the Spring Festival.

  In front of the stall in the vegetable market, I care about "has the price of vegetables gone up?" "Are there many local dishes?" In the cooked food area of the supermarket, I was told, "Be sure to pay attention to food hygiene, mark the date of production, and don’t sell expired food". In the busy New Year’s Street, ask carefully about the sales of New Year’s goods and the price of pork. When you walk into people’s homes, you often ask how the new year’s shopping is going.

  The mountain is a journey, the water is a journey, one branch and one leaf, and it is meticulous. In the footprint of the Spring Festival, it is "to do things that are beneficial to the people, no matter how small."

  I still remember that on the eve of the Spring Festival in 2018, when the General Secretary of the Supreme Leader walked to a cloth shoe display in Zhanqi Village, Chengdu, the villagers enthusiastically picked up a pair of cloth shoes and wanted to give them to the General Secretary. The General Secretary of the Supreme Leader smiled and said, "I will spend money to buy a pair!" The villagers responded: "This represents our wishes. It’s hard for you to go to the grassroots."

  "I am willing to take advantage of the wind to blow far away, and my hometown lane will be a spring." Tireless footprints, constant mourning, full of true feelings for the people, give people warmth and strength.

  Planning: Du Shangze

  Author: Lin Xinyu

  Editor: Yang Wanchen

  Proofreading: Wu Yue

  Photo: Xinhua News Agency reporter Ju Peng Xie Huanchi Yan Yan

  Vision: Lai Xiangdong Bi Xiaoyang

Non-genetic inheritors are willing to "paint" colorful life

Lacquerware is an important invention in chemical technology and arts and crafts in ancient China. Since the Neolithic Age, ancestors have known the performance of lacquer and used it to make utensils. Huizhou was famous for its lacquerware as early as the Tang Dynasty. In the Song Dynasty, Huizhou’s fine inlaid Luodian lacquerware was famous all over the country, and it was known as "Song inlaid". Huizhou is rich in lacquer trees. Huizhou lacquerware is made of natural raw lacquer as the main raw material, mixed with turquoise, cinnabar, coral, blue veins and cinnabar, etc., and is called "pineapple lacquerware" in ancient times. Pineapple lacquerware is the highest level representative of Huizhou lacquerware technology. However, this excellent traditional craft is also facing loss.

Gan Keke was born in Huang Shanren, Anhui Province in 1955. Willing to understand painting, good at carpentry, carving and fine design, lacquer art follows pure traditional techniques. After nearly 30 years of continuous exploration, innovation and practice, he revived the traditional Huizhou lacquering techniques "pineapple lacquer" (also known as rhinoceros skin lacquer) and "lacquered sand inkstone", which were on the verge of extinction, and revived their vitality, so he was named as the national inheritor of Huizhou lacquering techniques.

Gan Keke has perfected Huizhou lacquerware. His round box of "pineapple lacquer" is one of the four works of modern people collected by the Palace Museum in China. But he always said to people, "I am an old painter." "Historical Records" says that "the middle of the day will move, and the full moon will lose money." I am willing to say, "If I don’t be the first, I will be the old Huizhou lacquer. Nothing is perfect. The first is too perfect, and perfect things can’t be done." Gan said this, but he didn’t do it. He has reached the peak of Huizhou lacquerware.

Gan Keke began to learn carpentry after graduating from junior high school, and also studied painting and sculpture. Later, he made wooden models in Tunxi Log Club. Ten years of woodworking experience laid a solid foundation for his design and sculpture. In 1979, only 24-year-old Gan Erke entered Tunxi Lacquerware Craft Factory in Anhui Province, and first studied sculpture with the old artists in the factory. Because of his intelligence, high understanding, and good artistic skills, he made great progress in carving art. The next year, the factory sent him to Shanghai Arts and Crafts No.6 Factory to learn lacquer carving technology.

After returning from his studies in Shanghai, Gan Keke was promoted as the workshop director of the lacquer carving workshop. During this period, he had the opportunity to get in touch with Yu Jinhai, a lacquerware artist in Tunxi who was known as the "national hand of Chu lacquer" at that time. Because he likes diamonds and can bear hardships, most of Yu Jinhai’s lacquerware works are carved by him, and gradually he has mastered the essentials of lacquerware making.

In 1985, Gan Keke was transferred to Tunxi Arts and Crafts Institute, where he began to contact bodiless lacquerware. Ordinary lacquerware is made of wood, leather, metal, etc., and then painted with raw lacquer, while bodiless lacquerware is made of clay, gypsum, etc., and the carcass is removed after painted with raw lacquer, so bodiless lacquerware is more difficult and the process is more complicated. In Tunxi Arts and Crafts Institute, there are more people who are willing to contact, and their horizons are broader. From design, sculpture, production to lighting, he has integrated various techniques of lacquer making and laid a solid foundation.

In order to better inherit Huizhou lacquer craft, Gan Keke took seven students. Now they have been able to operate independently and use various lacquer making techniques flexibly, which can help Gan Keke make lacquerware, but even so, they can only make a dozen or twenty pieces a year. Although some people advised him to take advantage of the good market, he didn’t have to do it himself, and processed a batch and put it on the market. But he is willing to say: "Although money is good, but the mentality can’t be chaotic, people will be reflected in their works when they are impetuous. All my things must be excellent, and they must be kept and passed on. There are many kinds of traditional lacquer crafts in Huizhou. I want to calm down and restore them. I want people to see the brilliance of Huizhou lacquerware again through my hands. "

Ganerke has always been rooted in the tradition of lacquer art in China, and its raw materials and technology adhere to the ancient principles of making natural lacquer. Explore the greatest possibility of deepening the development of fine and elegant lacquer art technology, and push the deep essence of China lacquer art field and the representatives of rhinoceros skin paint, push-gloss paint, lacquer sand inkstone and fine lacquer surface decoration with emblem characteristics to a new height of inheriting tradition in China.

Gan Keke likes to put his philosophy of life into the process of making lacquerware, which proves each other, which makes his daily manual work seem to have a taste of self-meditation. He takes a fancy to the "degree" of doing things and being a man, and also to the creed of "being gentle as jade". In the eyes of people around him, the sweetness of life is extremely strict with the requirements of craftsmanship without any relaxation. However, he has always been gentle, moderate in words and deeds, not angry with others and rarely anxious. It is quite a gentleman’s wind-polishing his own temperament is just like polishing a beloved lacquer.